TG TherapeuticsTGTX saw its IBD SmartSelect Composite Rating rise to 97 Tuesday, up from 94 the day before. Please watch the video at Investors.com - Do Your Stocks Meet This Key Standard? Here's Why ...
TOKYO (AP) — Toyota reported a 7% year-on-year drop in its profit for April-September on Wednesday, as President Donald Trump’s tariffs slammed Japanese automakers, but it raised its forecast for the ...
If you do not want to deal with YouTube restrictions, you can rely on our API for audio streaming. The API allows you to fetch audio directly without needing cookies, making the process simpler and ...
Can you chip in? This year we’ve reached an extraordinary milestone: 1 trillion web pages preserved on the Wayback Machine. This makes us the largest public repository of internet history ever ...
Hyderabad: Chief Minister A Revanth Reddy has declared that the ‘Koti Deepotsavam’ programme, being organized to mark the auspicious Karthika Maasam, will be celebrated as a state festival from the ...
Chart does not reflect overnight price.
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701 ...
Rights May 31, 2023 May 31, 2023 Apr 22, 2022 Rights ratio: 1 share for every 2 held at a price of Rs 12.0 Bonus Oct 04, 2019 Oct 07, 2019 Aug 26, 2019 Bonus Ratio: 15 share(s) for every 100 shares ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results